1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Radioactive Tracer Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Radioactive Tracer Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Radioactive Tracer Market Regional Analysis
6.2 Europe Radioactive Tracer Market Revenue 2020-2030 (US$ Million)
6.3 Europe Radioactive Tracer Market Forecast Analysis
7. Europe Radioactive Tracer Market Analysis – by Tracer Type
7.1 Technetium-99m & Tc-97m
- 7.1.1 Overview
- 7.1.2 Technetium-99m & Tc-97m: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Iodine-131
- 7.2.1 Overview
- 7.2.2 Iodine-131: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Iron-59
- 7.3.1 Overview
- 7.3.2 Iron-59: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Lutetium-171
- 7.4.1 Overview
- 7.4.2 Lutetium-171: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.5 Rubidium Chloride & Ammonia
- 7.5.1 Overview
- 7.5.2 Rubidium Chloride & Ammonia: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.6 Scandium-46
- 7.6.1 Overview
- 7.6.2 Scandium-46: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.7 Seaborgium-269
- 7.7.1 Overview
- 7.7.2 Seaborgium-269: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.8 Hassium-269
- 7.8.1 Overview
- 7.8.2 Hassium-269: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.9 Gallium Citrate Ga 67
- 7.9.1 Overview
- 7.9.2 Gallium Citrate Ga 67: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.10 Prostate-Specific Membrane Antigen
- 7.10.1 Overview
- 7.10.2 Prostate-Specific Membrane Antigen: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.11 FDDNP & FDOPA
- 7.11.1 Overview
- 7.11.2 FDDNP & FDOPA: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.12 Phosphorus-32 & Chromium-51
- 7.12.1 Overview
- 7.12.2 Phosphorus-32 & Chromium-51: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.13 Thallium-201
- 7.13.1 Overview
- 7.13.2 Thallium-201: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.14 F-18 FDG
- 7.14.1 Overview
- 7.14.2 F-18 FDG: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.15 F-18 FAPI
- 7.15.1 Overview
- 7.15.2 F-18 FAPI: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.16 Ga-68 FAPI
- 7.16.1 Overview
- 7.16.2 Ga-68 FAPI: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.17 F-18 PSMA
- 7.17.1 Overview
- 7.17.2 F-18 PSMA: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.18 DOTATOC/DOTANOC/DOTATATE
- 7.18.1 Overview
- 7.18.2 DOTATOC/DOTANOC/DOTATATE: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Europe Radioactive Tracer Market Analysis – by Test Type
8.1 PET
- 8.1.1 Overview
- 8.1.2 PET: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 SPECT
- 8.2.1 Overview
- 8.2.2 SPECT: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Europe Radioactive Tracer Market Analysis – by Application
9.1 Oncology
- 9.1.1 Overview
- 9.1.2 Oncology: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Pulmonary
- 9.2.1 Overview
- 9.2.2 Pulmonary: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Neurology
- 9.3.1 Overview
- 9.3.2 Neurology: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Cardiology
- 9.4.1 Overview
- 9.4.2 Cardiology: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Europe Radioactive Tracer Market Analysis – by End User
10.1 Hospitals & Clinics
- 10.1.1 Overview
- 10.1.2 Hospitals & Clinics: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Diagnostic Centers
- 10.2.1 Overview
- 10.2.2 Diagnostic Centers: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.3 Academic & Research Institutes
- 10.3.1 Overview
- 10.3.2 Academic & Research Institutes: Europe Radioactive Tracer Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. Europe Radioactive Tracer Market – Europe Analysis
11.1 Overview
11.2 Europe
- 11.2.1 Europe Radioactive Tracer Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 Europe Radioactive Tracer Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 UK:
Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 UK: Europe Radioactive Tracer Market Breakdown, by Tracer Type
- 11.2.1.1.2 UK: Europe Radioactive Tracer Market Breakdown, by Test Type
- 11.2.1.1.3 UK: Europe Radioactive Tracer Market Breakdown, by Application
- 11.2.1.1.4 UK: Europe Radioactive Tracer Market Breakdown, by End User
- 11.2.1.2 Germany:
Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Germany: Europe Radioactive Tracer Market Breakdown, by Tracer Type
- 11.2.1.2.2 Germany: Europe Radioactive Tracer Market Breakdown, by Test Type
- 11.2.1.2.3 Germany: Europe Radioactive Tracer Market Breakdown, by Application
- 11.2.1.2.4 Germany: Europe Radioactive Tracer Market Breakdown, by End User
- 11.2.1.3 France:
Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 France: Europe Radioactive Tracer Market Breakdown, by Tracer Type
- 11.2.1.3.2 France: Europe Radioactive Tracer Market Breakdown, by Test Type
- 11.2.1.3.3 France: Europe Radioactive Tracer Market Breakdown, by Application
- 11.2.1.3.4 France: Europe Radioactive Tracer Market Breakdown, by End User
- 11.2.1.4 Russia:
Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.4.1 Russia: Europe Radioactive Tracer Market Breakdown, by Tracer Type
- 11.2.1.4.2 Russia: Europe Radioactive Tracer Market Breakdown, by Test Type
- 11.2.1.4.3 Russia: Europe Radioactive Tracer Market Breakdown, by Application
- 11.2.1.4.4 Russia: Europe Radioactive Tracer Market Breakdown, by End User
- 11.2.1.5 Italy:
Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.5.1 Italy: Europe Radioactive Tracer Market Breakdown, by Tracer Type
- 11.2.1.5.2 Italy: Europe Radioactive Tracer Market Breakdown, by Test Type
- 11.2.1.5.3 Italy: Europe Radioactive Tracer Market Breakdown, by Application
- 11.2.1.5.4 Italy: Europe Radioactive Tracer Market Breakdown, by End User
- 11.2.1.6 Rest of Europe:
Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.6.1 Rest of Europe: Europe Radioactive Tracer Market Breakdown, by Tracer Type
- 11.2.1.6.2 Rest of Europe: Europe Radioactive Tracer Market Breakdown, by Test Type
- 11.2.1.6.3 Rest of Europe: Europe Radioactive Tracer Market Breakdown, by Application
- 11.2.1.6.4 Rest of Europe: Europe Radioactive Tracer Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Rotem Industries Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 ABX advanced biochemical compounds GmbH
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Invicro LLC
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Cardinal Health Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Newcastle University
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Novartis AG
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Curium
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Blue Earth Diagnostics Limited
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 General Electric Co
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 IBA Radiopharma Solutions
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations